60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
Go back to 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial| (NASDAQ: SXTP) | Delayed: 1.71 -0.04 (2.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.75 | 52 Week High | $ | |||
| Open | $1.67 | 52 Week Low | $ | |||
| Day High | $1.82 | P/E | N/A | |||
| Day Low | $1.67 | EPS | $ | |||
| Volume | 24,775 | |||||
| (NASDAQ: SXTPW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 60,785 | |||||

